Document is current
Any future updates will be listed below
-
Authors
Kolnes, Kristoffer J.
Nilsen, Emelie T. F.
Brufladt, Steffen
Meadows, Allison M. https://orcid.org/0000-0002-7129-008X
Jeppesen, Per B. https://orcid.org/0000-0001-8042-7554
Skattebo, Øyvind https://orcid.org/0000-0003-0771-9715
Johansen, Egil I.
Birk, Jesper B. https://orcid.org/0000-0001-9775-4789
Højlund, Kurt
Hingst, Janne
Skålhegg, Bjørn S.
Kjøbsted, Rasmus https://orcid.org/0000-0002-0628-4994
Griffin, Julian L. https://orcid.org/0000-0003-1336-7744
Kolnes, Anders J. https://orcid.org/0000-0003-4607-9642
O’Rahilly, Stephen https://orcid.org/0000-0003-2199-4449
Wojtaszewski, Jørgen F. P. https://orcid.org/0000-0001-8185-3408
Jensen, Jørgen https://orcid.org/0000-0001-5851-220X
- License Information
-
More Information
Article History
Received: 14 August 2024
Accepted: 10 December 2024
First Online: 2 January 2025
Competing interests
: J.F.P.W. has ongoing collaborations with Pfizer Inc. and Novo Nordisk A/S unrelated to this study. J.F.P.W. holds shares in Pfizer Inc. and Novo Nordisk A/S. During 2024 J.F.P.W. was a consultant at Pfizer Inc. K.J.K. was appointed at Novo Nordisk A/S June 2024. The remaining authors declare no competing interests.
